- Home
- CVAC vs REAX Comparison
CVAC vs REAX Comparison
Compare CVAC & REAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- REAX
- Stock Information
- Founded
- CVAC 2000
- REAX 2018
- Country
- CVAC Germany
- REAX United States
- Employees
- CVAC N/A
- REAX N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- REAX
- Sector
- CVAC Health Care
- REAX
- Exchange
- CVAC Nasdaq
- REAX Nasdaq
- Market Cap
- CVAC 812.1M
- REAX 917.7M
- IPO Year
- CVAC 2020
- REAX N/A
- Fundamental
- Price
- CVAC $4.10
- REAX $4.54
- Analyst Decision
- CVAC Hold
- REAX Strong Buy
- Analyst Count
- CVAC 3
- REAX 3
- Target Price
- CVAC $10.00
- REAX $5.17
- AVG Volume (30 Days)
- CVAC 1.2M
- REAX 892.4K
- Earning Date
- CVAC 11-12-2024
- REAX 03-06-2025
- Dividend Yield
- CVAC N/A
- REAX N/A
- EPS Growth
- CVAC N/A
- REAX N/A
- EPS
- CVAC N/A
- REAX N/A
- Revenue
- CVAC $70,565,734.00
- REAX $1,095,350,000.00
- Revenue This Year
- CVAC $742.57
- REAX $79.64
- Revenue Next Year
- CVAC N/A
- REAX $29.97
- P/E Ratio
- CVAC N/A
- REAX N/A
- Revenue Growth
- CVAC 75.11
- REAX 81.37
- 52 Week Low
- CVAC $2.22
- REAX $2.16
- 52 Week High
- CVAC $5.28
- REAX $6.75
- Technical
- Relative Strength Index (RSI)
- CVAC 62.06
- REAX 46.96
- Support Level
- CVAC $3.89
- REAX $3.98
- Resistance Level
- CVAC $4.32
- REAX $4.63
- Average True Range (ATR)
- CVAC 0.33
- REAX 0.26
- MACD
- CVAC 0.03
- REAX 0.02
- Stochastic Oscillator
- CVAC 54.27
- REAX 59.57
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About REAX The Real Brokerage Inc.
The Real Brokerage Inc is a technology-powered real estate brokerage firm. It has developed, integrated, and adopted various mobile and desktop-focused technologies to create a comprehensive offering to its agents and to assist Real with its brokerage operations. The group delivers a cloud-based platform to improve efficiencies and empower real estate agents to provide a seamless end-to-end experience for homebuyers and sellers. The company generates its maximum revenue from the United States.